Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SDL.BOthis companySpan Divergent Limited	₹27.10	-7.66×	1.29×	1.11×	-14.86×	-948.6%	-9.7%	-21.8%	-14.5%	-16.8%	-20.3%	-3.0%	0.48×	-0.13×	-8.69×	1.1×	0.0%	2	—	2	C
BERLDRG.BOBeryl Drugs Limited	₹25.49	22.95×	0.99×	0.5×	4.91×	-329.6%	28.6%	4.8%	2.2%	4.3%	5.2%	-5.3%	0.25×	0.89×	2.71×	1.52×	0.0%	5	3.87	1	C-
EMMESSA.BOEmmessar Biotech & Nutrition Limited	₹23.98	29.09×	1.56×	34.19×	-3.96×	-56.4%	-241.7%	-392.0%	117.6%	5.4%	-12.0%	5.1%	0×	5.41×	-581.48×	20.27×	0.0%	3	—	3	B-
EVOQ.BOEvoq Remedies Ltd.	₹1.60	-25.2×	0.14×	0.24×	-30.58×	-7336.2%	0.1%	-5.9%	-0.9%	-0.5%	-3.2%	-4.7%	0×	-0.34×	0×	6.77×	0.0%	3	1.82	2	B-
GIANLIFE.BOGian Life Care Limited	₹4.27	-438.25×	0.85×	2.46×	16.61×	501.1%	81.9%	72.9%	-0.6%	-0.2%	-18.0%	1.6%	0.3×	-1.22×	8.79×	1.45×	0.0%	2	—	2	B-
NORRIS.BONorris Medicines Limited	₹14.25	-47.32×	-0.88×	1.63×	48.99×	-220.4%	47.1%	26.5%	-3.5%	1.9%	33.8%	4.3%	-1.42×	30.29×	0×	0.61×	0.0%	2	—	1	D+
Peer median	—	-25.2×	0.85×	1.63×	4.91×	-220.4%	28.6%	4.8%	-0.6%	1.9%	-3.2%	1.6%	0×	0.89×	0×	1.52×	0.0%	3	2.85	2	—